Tag: Genomic Medicine

07/29/2018 / / Biotechnology

Brief about the Genomic Medicine:
– The first two U.S.-approved autologous T-cell immunotherapies, Kymriah and Yescarta, are commercially available in 2018.
– Three leading gene therapy companies have been acquired in the last nine months for a combined $30 billion.
– Catalysts over the next year are poised to drive group valuations.

Read the Post Genomic Medicine: Catch The Gene Therapy Wave